-
article
Walmsley SL, Lovblom LE, Boyachuk B, Cooper C, Martel-Laferrière V, Loutfy M, Vachon ML, Haider S, Aldebes P, Colwill K, Gingras AC, Qi F, Klein MB
SARS-CoV-2 Infection and COVID-19 Vaccine Antibody Responses in Two Canadian Cohorts of Persons Living with HIV
Antibodies (Basel)
15 (2), 2026.
-
article
Mitha E, Ferguson M, Wilhase AC, De Looze F, Vachon ML, Stacey H, Rasalam R, Nozaki M, Smith WB, Schwarz TF, Hailemariam HA, Deraedt Q, Gérard C, Vanden Abeele C, Damaso S, Descamps D, Hill J, Dasyam D, Van Gucht J, Hulstrøm V
Immunogenicity and Safety of the AS01E-adjuvanted Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine in Adults Aged 18-49 Years at Increased Risk of RSV Disease Compar…
Clin Infect Dis
82 (5), 2026.
-
article
Elakpa DN, Lawton D, Tooley TH, van Rooyen K, Bruneau J, Cooper C, Dickie M, Feld JJ, Janjua NZ, King A, Kronfli N, Presseau J, Wilson J, Vachon ML, Fontaine G, On Hepatitis C CanHepC OBOTCN
The 14th Canadian Symposium on Hepatitis C Virus: From research breakthroughs to equitable health care for priority populations
Can Liver J
8 (4), 2025.